Filing Details
- Accession Number:
- 0001104659-13-069573
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-12 17:26:44
- Reporting Period:
- 2013-09-11
- Filing Date:
- 2013-09-12
- Accepted Time:
- 2013-09-12 17:26:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1544227 | Ovascience Inc. | OVAS | Pharmaceutical Preparations (2834) | 451472564 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1187407 | A Christopher Bleck | C/O Ovascience, Inc., 215 First Street, Suite 240 Cambridge MA 02142 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-09-11 | 2,000 | $11.15 | 2,000 | No | 4 | P | Indirect | By Christopher Bleck Revocable Trust dated July 30, 2009 |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Christopher Bleck Revocable Trust dated July 30, 2009 |
Footnotes
- The trustees of the Christopher Bleck Revocable Trust dated July 30, 2009 are the reporting person and his spouse. They jointly exercise voting and investment power over the shares of record held by the trust.